Search Result "Interleukin-6 inhibitor (IL-6)"
Effects of Interleukin 1β (IL-1β) and IL-1β/Interleukin 6 (IL-6) Combinations on Drug Metabolizing Enzymes in Human Hepatocyte Culture
Journal: Current Drug Metabolism
Volume: 13 Issue: 7 Year: 2012 Page: 930-937
Author(s): Leslie J. Dickmann,Sonal K. Patel,Larry C. Wienkers,J. Greg Slatter
Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 3 Year: 2008 Page: 235-246
Author(s): Simon A. Jones, Gareth W. Jones, Anwen S. Williams, Mari A. Nowell
Cardiovascular Biology of Interleukin-6
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1809-1821
Author(s): Mahinda Y. Abeywardena, Wayne R. Leifert, Kirsty E. Warnes, Jose N. Varghese, Richard J. Head
Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 36 Year: 2018 Page: 4785-4806
Author(s): Nirmala Chandralega Kampan,Sue D. Xiang,Orla M. McNally,Andrew N. Stephens,Michael A. Quinn,Magdalena Plebanski
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascularand Respiratory Outcomes
Journal: Protein & Peptide Letters
Volume: 31 Issue: 3 Year: 2024 Page: 178-191
Author(s):
IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 288-300
Author(s): Yoshiyuki Ohsugi, Tadamitsu Kishimoto
Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2187-2197
Author(s): Xiao Liu, Andrew J. Teichtahl, Ian P. Wicks
Curcumin: An Effective Inhibitor of Interleukin-6
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 921-931
Author(s): Morteza Ghandadi,Amirhossein Sahebkar
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 34 Year: 2023 Page: 2752-2762
Author(s): Israa M. Shamkh,Enas. S. Radwan,Mohamed F. AlAjmi,Nouf Khalifa Alaqeel,Ibrahim A. Ibrahim,Mohammad Shahbaz Khan,Tomasz M. KarpiÅski,Reem M. Aljowaie
Anti-Interleukin-6 Therapy for Crohns Disease
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 4 Year: 2003 Page: 295-305
Author(s): H. Ito